Year |
Citation |
Score |
2023 |
Xu Q, Elrefaei M, Taupin JL, Hitchman KM, Hiho S, Gareau A, Iasella C, Marrari M, Belousova N, Bettinotti M, Narula T, Alvarez F, Sanchez PG, Levvey B, Westall G, et al. Chronic Lung Allograft Dysfunction is Associated with an Increased Number of Non-HLA Antibodies. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 38141896 DOI: 10.1016/j.healun.2023.12.007 |
0.338 |
|
2022 |
Puttarajappa CM, Tevar AD, Hoffman W, Degenholtz H, Schinstock CA, Gunabushanam V, Zeevi A, Xu Q, Hariharan S. Virtual crossmatch for deceased donor kidney transplantation in the United States: A survey of histocompatibility lab directors and transplant surgeons. Human Immunology. PMID 36581507 DOI: 10.1016/j.humimm.2022.12.001 |
0.391 |
|
2022 |
Suri RS, Lee JY, Ban MR, Shrum B, Tutunea-Fatan E, Ismail OZ, Leckie S, McIntyre A, Xu Q, Lee SH, de Chickera S, Hegele RA, Gunaratnam L. Defective KIM-1 phagocytosis does not predispose to acute graft dysfunction after kidney transplantation in humans. Kidney International. PMID 35636639 DOI: 10.1016/j.kint.2022.05.006 |
0.369 |
|
2022 |
Mangiola M, Marrari M, Xu Q, Sanchez PG, Zeevi A. Approaching the sensitized lung patient: risk assessment for donor acceptance. Journal of Thoracic Disease. 13: 6725-6736. PMID 34992848 DOI: 10.21037/jtd-2021-21 |
0.386 |
|
2021 |
Feingold B, Rose-Felker K, West SC, Zinn MD, Berman P, Moninger A, Huston A, Stinner B, Xu Q, Zeevi A, Miller SA. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation. Pediatric Transplantation. e14124. PMID 34420244 DOI: 10.1111/petr.14124 |
0.31 |
|
2021 |
Sriwattanakomen R, Xu Q, Demehin M, Shullo MA, Mangiola M, Hickey GW, Sciortino CM, Horn ET, Keebler ME, Zeevi A. Impact of carfilzomib-based desensitization on heart transplantation of sensitized candidates. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 33785250 DOI: 10.1016/j.healun.2021.03.001 |
0.399 |
|
2020 |
Hosseini-Moghaddam SM, Xu Q, Jevnikar AM, House AA, Luke P, Campigotto A, Kum JJ, Singh G, Alharbi H, Speechley MR. The Effect of Human Leukocyte Antigen-A1 and B35-cw4 on Sustained BK Polyomavirus DNAemia after Renal Transplantation. Clinical Transplantation. e14110. PMID 33053214 DOI: 10.1111/ctr.14110 |
0.384 |
|
2020 |
Iasella CJ, Ensor CR, Marrari M, Mangiola M, Xu Q, Nolley E, Moore CA, Morrell MR, Pilewski JM, Sanchez PG, McDyer JF, Zeevi A. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. PMID 32981841 DOI: 10.1016/j.healun.2020.09.003 |
0.368 |
|
2019 |
Xu Q, McAlister VC, Leckie S, House AA, Skaro A, Marotta P. Angiotensin II Type I Receptor Agonistic Autoantibodies are Associated with Poor Allograft Survival in Liver Retransplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 31419065 DOI: 10.1111/ajt.15571 |
0.358 |
|
2019 |
Xu Q, Shrum B, Leckie S, Skaro A, McAlister VC. The impact of alloantibodies directed against the second donor on long-term outcomes of repeat liver transplantation. Hepatobiliary Surgery and Nutrition. 8: 246-252. PMID 31245404 DOI: 10.21037/hbsn.2019.01.14 |
0.365 |
|
2013 |
Umeshappa CS, Nanjundappa RH, Xie Y, Freywald A, Xu Q, Xiang J. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency. Immunology. 138: 298-306. PMID 23113741 DOI: 10.1111/imm.12033 |
0.369 |
|
2011 |
Ankathatti Munegowda M, Deng Y, Chibbar R, Xu Q, Freywald A, Mulligan SJ, van Drunen Littel-van den Hurk S, Sun D, Xiong S, Xiang J. A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis. Journal of Clinical Immunology. 31: 811-26. PMID 21674137 DOI: 10.1007/S10875-011-9549-Z |
0.309 |
|
2010 |
Bobadilla JL, Jankowska-Gan E, Xu Q, Haynes LD, Munoz del Rio A, Meyer K, Greenspan DS, De Oliveira N, Burlingham WJ, Maloney JD. Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome. Chest. 138: 363-70. PMID 20418369 DOI: 10.1378/Chest.09-2610 |
0.568 |
|
2009 |
Xu Q, Lee J, Keller M, Burlingham WJ. Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft: possible relevance to superior graft survival of HLA class II closely matched renal allografts. Transplant Immunology. 20: 203-8. PMID 19166935 DOI: 10.1016/J.Trim.2008.12.005 |
0.637 |
|
2009 |
Xu Q, Lee J, Keller M, Burlingham WJ. Corrigendum to “Analysis of indirect pathway CD4+ T cells in a patient with metastable tolerance to a kidney allograft” [Transpl Immunol. 20 (2009) 203–208] Transplant Immunology. 21: 247. DOI: 10.1016/J.Trim.2009.06.005 |
0.599 |
|
2008 |
Bobadilla JL, Love RB, Jankowska-Gan E, Xu Q, Haynes LD, Braun RK, Hayney MS, Munoz del Rio A, Meyer K, Greenspan DS, Torrealba J, Heidler KM, Cummings OW, Iwata T, Brand D, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. American Journal of Respiratory and Critical Care Medicine. 177: 660-8. PMID 18174545 DOI: 10.1164/Rccm.200612-1901Oc |
0.624 |
|
2007 |
Burlingham WJ, Love RB, Jankowska-Gan E, Haynes LD, Xu Q, Bobadilla JL, Meyer KC, Hayney MS, Braun RK, Greenspan DS, Gopalakrishnan B, Cai J, Brand DD, Yoshida S, Cummings OW, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. The Journal of Clinical Investigation. 117: 3498-506. PMID 17965778 DOI: 10.1172/Jci28031 |
0.655 |
|
2007 |
Derks RA, Jankowska-Gan E, Xu Q, Burlingham WJ. Dendritic cell type determines the mechanism of bystander suppression by adaptive T regulatory cells specific for the minor antigen HA-1. Journal of Immunology (Baltimore, Md. : 1950). 179: 3443-51. PMID 17785778 DOI: 10.4049/Jimmunol.179.6.3443 |
0.62 |
|
2007 |
Xu Q, Lee J, Jankowska-Gan E, Schultz J, Roenneburg DA, Roennburg DA, Haynes LD, Kusaka S, Sollinger HW, Knechtle SJ, VanBuskirk AM, Torrealba JR, Burlingham WJ. Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. Journal of Immunology (Baltimore, Md. : 1950). 178: 3983-95. PMID 17339499 DOI: 10.4049/Jimmunol.178.6.3983 |
0.648 |
|
2007 |
Xu Q, Burlingham WJ. 22-OR: A subset of recipient CD4+T cells is capable of recognizing a tolerogenic HLA-B allopeptide presented by renal transplant donor DQ8 or recipient DQ7 Human Immunology. 68: S111. DOI: 10.1016/J.Humimm.2007.08.214 |
0.678 |
|
2004 |
Torrealba JR, Katayama M, Fechner JH, Jankowska-Gan E, Kusaka S, Xu Q, Schultz JM, Oberley TD, Hu H, Hamawy MM, Jonker M, Wubben J, Doxiadis G, Bontrop R, Burlingham WJ, et al. Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. Journal of Immunology (Baltimore, Md. : 1950). 172: 5753-64. PMID 15100322 DOI: 10.4049/Jimmunol.172.9.5753 |
0.646 |
|
Show low-probability matches. |